formic acid;4-[[4-[(7-isocyano-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[(3-methyl-1,2-oxazol-5-yl)methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-1,2-oxazol-3-yl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-[(4-oxidomorpholin-4-ium-4-yl)methyl]-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]methoxy]isoindole-1,3-dione

C153H158F3N25O27 — CID 158861800

About formic acid;4-[[4-[(7-isocyano-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[(3-methyl-1,2-oxazol-5-yl)methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-1,2-oxazol-3-yl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-[(4-oxidomorpholin-4-ium-4-yl)methyl]-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]methoxy]isoindole-1,3-dione

formic acid;4-[[4-[(7-isocyano-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[(3-methyl-1,2-oxazol-5-yl)methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-1,2-oxazol-3-yl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-[(4-oxidomorpholin-4-ium-4-yl)methyl]-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]methoxy]isoindole-1,3-dione (PubChem CID 158861800) has the molecular formula C153H158F3N25O27 and a molecular weight of 2836.09 g/mol. Its IUPAC name is formic acid;4-[[4-[(7-isocyano-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[(3-methyl-1,2-oxazol-5-yl)methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-1,2-oxazol-3-yl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-[(4-oxidomorpholin-4-ium-4-yl)methyl]-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]methoxy]isoindole-1,3-dione.

Molecular Properties

• Compound Name: formic acid;4-[[4-[(7-isocyano-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[(3-methyl-1,2-oxazol-5-yl)methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-1,2-oxazol-3-yl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-[(4-oxidomorpholin-4-ium-4-yl)methyl]-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]methoxy]isoindole-1,3-dione
• PubChem CID: 158861800
• Molecular Formula: C153H158F3N25O27
• Molecular Weight: 2836.09 g/mol
• Exact Mass: 2834.17
• IUPAC Name: formic acid;4-[[4-[(7-isocyano-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[(3-methyl-1,2-oxazol-5-yl)methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-1,2-oxazol-3-yl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-[(4-oxidomorpholin-4-ium-4-yl)methyl]-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]methoxy]isoindole-1,3-dione
• SMILES: C=C1CCC(N2C(=O)c3cccc(OCc4ccc(CN5CCn6c(nnc6C(F)(F)F)C5)cc4)c3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4cc(C)no4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4cc(CN5CCOCC5)on4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4ccc(CN5CCOCC5)cn4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4ccc(C[N+]5([O-])CCOCC5)cn4)cccc3C2=O)C(=O)N1.O=CO.[C-]#[N+]c1ccc2c(c1)CN(Cc1ccc(COc3cccc4c3CN([C@H]3CCC(=C)NC3=O)C4=O)cc1)CC2
• InChI: InChI=1S/C32H30N4O3.C28H25F3N6O4.C25H28N4O5.C25H28N4O4.C23H26N4O5.C19H19N3O4.CH2O2/c1-21-6-13-29(31(37)34-21)36-19-28-27(32(36)38)4-3-5-30(28)39-20-23-9-7-22(8-10-23)17-35-15-14-24-11-12-26(33-2)16-25(24)18-35;1-16-5-10-20(24(38)32-16)37-25(39)19-3-2-4-21(23(19)26(37)40)41-15-18-8-6-17(7-9-18)13-35-11-12-36-22(14-35)33-34-27(36)28(29,30)31;1-17-5-8-22(24(30)27-17)28-14-21-20(25(28)31)3-2-4-23(21)34-16-19-7-6-18(13-26-19)15-29(32)9-11-33-12-10-29;1-17-5-8-22(24(30)27-17)29-15-21-20(25(29)31)3-2-4-23(21)33-16-19-7-6-18(13-26-19)14-28-9-11-32-12-10-28;1-15-5-6-20(22(28)24-15)27-13-19-18(23(27)29)3-2-4-21(19)31-14-16-11-17(32-25-16)12-26-7-9-30-10-8-26;1-11-6-7-16(18(23)20-11)22-9-15-14(19(22)24)4-3-5-17(15)25-10-13-8-12(2)21-26-13;2-1-3/h3-5,7-12,16,29H,1,6,13-15,17-20H2,(H,34,37);2-4,6-9,20H,1,5,10-15H2,(H,32,38);2-4,6-7,13,22H,1,5,8-12,14-16H2,(H,27,30);2-4,6-7,13,22H,1,5,8-12,14-16H2,(H,27,30);2-4,11,20H,1,5-10,12-14H2,(H,24,28);3-5,8,16H,1,6-7,9-10H2,2H3,(H,20,23);1H,(H,2,3)/t29-;;;;;;/m0....../s1
• InChIKey: JATCJFFNNUTEHC-KFLYQUJZSA-N
• XLogP: 16.74
• TPSA: 582.83 Ų
• H-Bond Donors: 7
• H-Bond Acceptors: 37
• Rotatable Bonds: 34
• Heavy Atoms: 208
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2836.09
LogP ≤ 5	16.74
H-Bond Donors ≤ 5	7
H-Bond Acceptors ≤ 10	37

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_2', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of formic acid;4-[[4-[(7-isocyano-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[(3-methyl-1,2-oxazol-5-yl)methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-1,2-oxazol-3-yl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-[(4-oxidomorpholin-4-ium-4-yl)methyl]-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]methoxy]isoindole-1,3-dione?

The IUPAC name of formic acid;4-[[4-[(7-isocyano-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[(3-methyl-1,2-oxazol-5-yl)methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-1,2-oxazol-3-yl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-[(4-oxidomorpholin-4-ium-4-yl)methyl]-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]methoxy]isoindole-1,3-dione (CID 158861800) is formic acid;4-[[4-[(7-isocyano-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[(3-methyl-1,2-oxazol-5-yl)methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-1,2-oxazol-3-yl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-[(4-oxidomorpholin-4-ium-4-yl)methyl]-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]methoxy]isoindole-1,3-dione.

What is the SMILES notation for formic acid;4-[[4-[(7-isocyano-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[(3-methyl-1,2-oxazol-5-yl)methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-1,2-oxazol-3-yl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-[(4-oxidomorpholin-4-ium-4-yl)methyl]-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]methoxy]isoindole-1,3-dione?

The canonical SMILES for formic acid;4-[[4-[(7-isocyano-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[(3-methyl-1,2-oxazol-5-yl)methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-1,2-oxazol-3-yl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-[(4-oxidomorpholin-4-ium-4-yl)methyl]-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]methoxy]isoindole-1,3-dione is C=C1CCC(N2C(=O)c3cccc(OCc4ccc(CN5CCn6c(nnc6C(F)(F)F)C5)cc4)c3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4cc(C)no4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4cc(CN5CCOCC5)on4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4ccc(CN5CCOCC5)cn4)cccc3C2=O)C(=O)N1.C=C1CCC(N2Cc3c(OCc4ccc(C[N+]5([O-])CCOCC5)cn4)cccc3C2=O)C(=O)N1.O=CO.[C-]#[N+]c1ccc2c(c1)CN(Cc1ccc(COc3cccc4c3CN([C@H]3CCC(=C)NC3=O)C4=O)cc1)CC2.

What is the InChIKey of formic acid;4-[[4-[(7-isocyano-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[(3-methyl-1,2-oxazol-5-yl)methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-1,2-oxazol-3-yl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-[(4-oxidomorpholin-4-ium-4-yl)methyl]-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]methoxy]isoindole-1,3-dione?

The InChIKey is JATCJFFNNUTEHC-KFLYQUJZSA-N. The full InChI is InChI=1S/C32H30N4O3.C28H25F3N6O4.C25H28N4O5.C25H28N4O4.C23H26N4O5.C19H19N3O4.CH2O2/c1-21-6-13-29(31(37)34-21)36-19-28-27(32(36)38)4-3-5-30(28)39-20-23-9-7-22(8-10-23)17-35-15-14-24-11-12-26(33-2)16-25(24)18-35;1-16-5-10-20(24(38)32-16)37-25(39)19-3-2-4-21(23(19)26(37)40)41-15-18-8-6-17(7-9-18)13-35-11-12-36-22(14-35)33-34-27(36)28(29,30)31;1-17-5-8-22(24(30)27-17)28-14-21-20(25(28)31)3-2-4-23(21)34-16-19-7-6-18(13-26-19)15-29(32)9-11-33-12-10-29;1-17-5-8-22(24(30)27-17)29-15-21-20(25(29)31)3-2-4-23(21)33-16-19-7-6-18(13-26-19)14-28-9-11-32-12-10-28;1-15-5-6-20(22(28)24-15)27-13-19-18(23(27)29)3-2-4-21(19)31-14-16-11-17(32-25-16)12-26-7-9-30-10-8-26;1-11-6-7-16(18(23)20-11)22-9-15-14(19(22)24)4-3-5-17(15)25-10-13-8-12(2)21-26-13;2-1-3/h3-5,7-12,16,29H,1,6,13-15,17-20H2,(H,34,37);2-4,6-9,20H,1,5,10-15H2,(H,32,38);2-4,6-7,13,22H,1,5,8-12,14-16H2,(H,27,30);2-4,6-7,13,22H,1,5,8-12,14-16H2,(H,27,30);2-4,11,20H,1,5-10,12-14H2,(H,24,28);3-5,8,16H,1,6-7,9-10H2,2H3,(H,20,23);1H,(H,2,3)/t29-;;;;;;/m0....../s1.

What are the key properties of formic acid;4-[[4-[(7-isocyano-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[(3-methyl-1,2-oxazol-5-yl)methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-1,2-oxazol-3-yl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-[(4-oxidomorpholin-4-ium-4-yl)methyl]-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]methoxy]isoindole-1,3-dione?

formic acid;4-[[4-[(7-isocyano-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[(3-methyl-1,2-oxazol-5-yl)methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-1,2-oxazol-3-yl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-[(4-oxidomorpholin-4-ium-4-yl)methyl]-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]methoxy]isoindole-1,3-dione has a molecular weight of 2836.09 g/mol, XLogP of 16.74, 34 rotatable bonds, 7 hydrogen bond donors, and 37 hydrogen bond acceptors.

Where does this data come from?

All data for formic acid;4-[[4-[(7-isocyano-3,4-dihydro-1H-isoquinolin-2-yl)methyl]phenyl]methoxy]-2-[(3S)-6-methylidene-2-oxopiperidin-3-yl]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[(3-methyl-1,2-oxazol-5-yl)methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-1,2-oxazol-3-yl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-(morpholin-4-ylmethyl)-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[5-[(4-oxidomorpholin-4-ium-4-yl)methyl]-2-pyridinyl]methoxy]-3H-isoindol-1-one;2-(6-methylidene-2-oxopiperidin-3-yl)-4-[[4-[[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methyl]phenyl]methoxy]isoindole-1,3-dione is sourced from PubChem (CID 158861800), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).